Blood testing miniaturisation – opportunities, trends and challenges. Dr Al Edwards (University of Southampton)

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-05-17 Abstract: Although the need for better diagnostics, especially point-of-care testing, is clear, the uptake of novel technology lags a long way behind demonstration and research papers. Using several case studies from my own research, alongside insight from current state-of-the art notably in diagnostics for microbiology and infection, I will outline the technological basis for bioassay miniaturisation (i.e. tiny blood tests) and discuss the diagnostics innovation pathway. Examples will include a review of >10 years developing microfluidic quantitative multiplex immunoassays that can measure multiple biomarkers in blood, as well as our latest developments in measuring platelet cell function directly in blood. Bio: With a background in fundamental immunology combined with expertise in biochemical engineering, Al Edwards is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology. The two main challenges he currently work on are the development of affordable microfluidic technology for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines. This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.